‘ImmunoAct’ developed by IIT Bombay and Tata Memorial Hospital is a special type of therapy. Which has been given to 15 patients in India. According to the news published in Indian Express, three of them have successfully recovered from cancer. Dr. Gupta, the first professional patient to be declared free from cancer, had a special conversation with the media. A few months ago, India’s drug regulator ‘Central Drugs Standard Control Organization’ (CDSCO) has approved the commercial use of CAR-T cell therapy. Under this therapy, the patient’s immune system is genetically…
Read MoreFirst patient free of cancer Indigenous CAR T cell therapy brings treatment cost down from Rs 4 crore to Rs 40 lakh
